OSM-SMI-10B (Fig. 7A,), a derivative of OSM-SMI-10 (patent pending) was subsequently synthesized and identified as a hit based on its ability to significantly reduce OSM-induced STAT3 phosphorylation in cancer cells upon co-incubation with OSM as measured by ELISA44. Here, STAT3 is linked to cancer.